Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population
Authors:
- 14 January 2022
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 41 (5) , 1359-1369
Abstract
Background An association between ANXA1, FPR1 and FPR2 gene polymorphisms and the patho-physiology of many human diseases was suggested by numerous studies. Objective Our study aimed to evaluate association between common polymorphisms in the 9q21.13 and 19q13.41 and susceptibility to systemic lupus erythematosus (SLE) in the Tunisian population. Materials We performed a case–control study on 107 Tunisian SLE patients and 122 healthy controls to explore 9 polymorphisms of the three studied genes: rs2811226 and rs3739959 (ANXA1), rs5030880, rs1042229, rs1461765570, rs17849971, rs867228 (FPR1), rs17694990 and rs11666254 (FPR2). Results Four polymorphisms were found to be linked with SLE susceptibility: rs3739959-ANXA1 > G and GG (p = 0.021, OR = 1.73 and p = 0.014, OR = 2.06 respectively), rs867228-FPR1 > TT (p = 0.014, OR = 4.59), rs11666254-FPR2 > GG (p = 0.019, OR = 8.34) and rs17694990-FPR2 > T (p = 0.05, OR = 1.506). In homogenous groups of SLE patients depending on clinical manifestations and serological results, previous associations were confirmed with a panoply of manifestations of lupus including lupus nephritis, malar rash, mouth ulceration and hypocomplementia. Conclusion Our study showed an association between ANXA1 > rs3739959, FPR1 > rs867228, FPR2 > rs11666254, FPR2 > rs17694990 and SLE susceptibility. Our results also showed a strong association between the two ANXA1 studied SNPs and LN which allowed us to suggest these two SNPs as biomarkers of LN development in SLE. Further research is needed to understand by which mechanism the gene variants affect susceptibility to SLE. Key Points • Lupus erythematosus is an autoimmune disease in which a panoply of factors are implicated • Annexin A1 interaction with its receptors are suggested as a target in therapy of a panoply of human disease in particular cancers • The present results highlighted the implication of Annexin A1 and its receptors gene polymorphisms in the physiopathology of lupus, in particular in the involvement of renal and cutaneous lesionsKeywords
This publication has 33 references indexed in Scilit:
- Hematological Disorders in Patients with Systemic Lupus ErythematosusThe Open Rheumatology Journal, 2013
- V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporinsBiochemical Journal, 2013
- Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and Aspirin exacerbated respiratory diseasesJournal of Human Genetics, 2012
- Anti‐annexin 1 antibodies: A new diagnostic marker in the serum of patients with discoid lupus erythematosusExperimental Dermatology, 2010
- Formylpeptide Receptor Single Nucleotide Polymorphism 348T>C and Its Relationship to Polymorphonuclear Leukocyte Chemotaxis in Aggressive PeriodontitisJournal of Periodontology, 2009
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) FamilyPharmacological Reviews, 2009
- Annexin 1 Cleavage in Activated NeutrophilsJournal of Biological Chemistry, 2007
- SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism lociCell Research, 2005
- Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defenseThe FASEB Journal, 2003
- Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1RGenes & Immunity, 2001